购物车
您的购物车当前为空
AZD2716是一种选择性分泌型磷脂酶A2(sPLA2)抑制剂,可抑制sPLA2-IIa、sPLA2-V 和sPLA2-X,其IC₅₀分别为10 nM、40 nM 和400 nM。AZD2716可减少促炎性脂质的生成,从而降低巨噬细胞活化及泡沫细胞形成,并被用于sPLA2相关动脉粥样硬化及炎症性疾病的研究。
AZD2716是一种选择性分泌型磷脂酶A2(sPLA2)抑制剂,可抑制sPLA2-IIa、sPLA2-V 和sPLA2-X,其IC₅₀分别为10 nM、40 nM 和400 nM。AZD2716可减少促炎性脂质的生成,从而降低巨噬细胞活化及泡沫细胞形成,并被用于sPLA2相关动脉粥样硬化及炎症性疾病的研究。

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,230 | 现货 | |
| 5 mg | ¥ 3,750 | 现货 | |
| 10 mg | ¥ 5,330 | 现货 | |
| 25 mg | ¥ 7,880 | 现货 | |
| 50 mg | ¥ 10,800 | 现货 | |
| 100 mg | ¥ 14,600 | 现货 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | AZD2716 is a selective secretory phospholipase A2(sPLA2) inhibitor, which can inhibit sPLA2-IIa, sPLA2-V and sPLA2-X, and its IC₅₀ is 10 nM, 40 nM and 400 nM respectively. AZD2716 can reduce the production of pro-inflammatory lipids, thus reducing macrophage activation and foam cell formation, and has been used in the study of atherosclerosis and inflammatory diseases related to sPLA2. |
| 靶点活性 | SPLA2 IIa:10 nM, SPLA2 X:400 nM, SPLA2 V:40 nM |
| 分子量 | 373.44 |
| 分子式 | C24H23NO3 |
| CAS No. | 1845753-81-2 |
| Smiles | C(N)(=O)C1=C(C=C(CC2=CC=CC=C2)C=C1)C3=CC(C[C@H](C(O)=O)C)=CC=C3 |
| 密度 | 1.190 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 10 mg/mL (26.78 mM), Sonication and heating are recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。 | ||||||||||||||||||||||||||
对于不同动物的给药剂量换算,您也可以参考 更多